Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 81, 2021 - Issue 8
Submit an article Journal homepage
1,652
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Reference interval for type III procollagen (PIIINP) using the Advia centaur PIIINP assay in adults and elderly

Paul Pettersson-Pabloa Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden;b School of Medicine, Faculty of Medicine, Örebro University, Örebro, SwedenORCID Iconhttps://orcid.org/0000-0001-8458-6448
ORCID Icon,
Dieter Samyna Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden;b School of Medicine, Faculty of Medicine, Örebro University, Örebro, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0381-251X
ORCID Icon,
Jamil Wasimc Department of Dermatology, School of Medical Sciences, Örebro University Hospital, Örebro, Sweden;d Faculty of Medicine, Section of Medical Sciences, Örebro University, Örebro, Sweden
&
Martin Vinka Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden;b School of Medicine, Faculty of Medicine, Örebro University, Örebro, SwedenORCID Iconhttps://orcid.org/0000-0002-4256-6008
ORCID Icon
Pages 649-652 | Received 26 Jul 2021, Accepted 26 Oct 2021, Published online: 15 Nov 2021

References

  • Warren RB, Weatherhead SC, Smith CH, et al. British association of dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Br J Dermatol. 2016;175(1):23–44.
  • Lammi L, Ryhanen L, Lakari E, et al. Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med. 1999;159(3):818–823.
  • Piovesan A, Terzolo M, Reimondo G, et al. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res. 1994;26(05):234–437.
  • Hakala M, Aman S, Luukkainen R, et al. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54(11):886–890.
  • Boffa MJ, Smith A, Chalmers RJ, et al. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients. Br J Dermatol. 1996;135(4):538–544.
  • Maurice PD, Maddox AJ, Green CA, et al. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. Br J Dermatol. 2005;152(3):451–458.
  • Knudsen CS, Heickendorff L, Nexo E. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA centaur platform. Validation, reference interval and comparison to UniQ RIA. Clin Chem Lab Med. 2014;52(2):237–241.
  • Tukey JW. Exploratory data analysis. Addison-Wesley Pub; 1977.
  • Boyd JC. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guidelines, CLSI document C28-A3. 2010.
  • Sinton TJ, Cowley DM, Bryant SJ. Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem. 1986;32(1 Pt 1):76–79.
  • Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem. 1990;36(2):265–270.
  • Box GaC D. An analysis of transformations. J R Stat Soc. 1964;26:211–252.
  • Sanyal A, Cusi K, Hartman ML, et al. Cytokeratin-18 and enhanced liver fibrosis scores in type 1 and type 2 diabetes and effects of two different insulins. J Investig Med. 2018;66(3):661–668.
  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–1143.
  • Foroughi M, Maghsoudi Z, Khayyatzadeh S, et al. Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver. Adv Biomed Res. 2016;5:28.
  • Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol. 2007;42(7):573–582.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.